Innate immunity in myasthenia gravis thymus: Pathogenic effects of Toll-like receptor 4 signaling on autoimmunity

Journal of Autoimmunity

Volumn 52, Issue , 2014, Pages 74-89

  Cordiglieri, Chiara ^a   Marolda, Roberta ^a   Franzi, Sara ^a   Cappelletti, Cristina ^a   Giardina, Carmelo ^b   Motta, Teresio ^b   Baggi, Fulvio ^a   Bernasconi, Pia ^a   Mantegazza, Renato ^a   Cavalcante, Paola ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b BOLOGNINI HOSPITAL   (Italy)

Author keywords

Chemokines; Dendritic cells; Myasthenia gravis; Regulatory T cells; Thymus; TLR4

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHOLINERGIC RECEPTOR; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; MACROPHAGE DERIVED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR 4;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL INTERACTION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DENDRITIC CELL; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DYSREGULATION; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MALE; MOLECULAR IMAGING; MYASTHENIA GRAVIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; THYMECTOMY; THYMI EPITHELIUM CELL; THYMUS; ANIMAL TISSUE; COCULTURE; MAJOR CLINICAL STUDY; T LYMPHOCYTE; THYMIC EPITHELIAL CELL; ADOLESCENT; ANIMAL; CELL COMMUNICATION; CELL CULTURE; GENETICS; IMMUNOLOGY; LEWIS RAT; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; AUTOIMMUNITY; CELL COMMUNICATION; CELLS, CULTURED; CHEMOKINE CCL17; CHEMOKINE CCL22; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNITY, INNATE; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RATS; RATS, INBRED LEW; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; THYMUS GLAND; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 84904339949     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.12.013     Document Type: Article

References (68)

1. Cavalcante P., Bernasconi P., Mantegazza R. Autoimmune mechanisms in myasthenia gravis. Curr Opin Neurol 2012, 25:621-629.
2. Marx A., Pfister F., Schalke B., Saruhan-Direskeneli G., Melms A., Strobel P. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 2013, 12:875-884.
3. Cavalcante P., Le Panse R., Berrih-Aknin S., Maggi L., Antozzi C., Baggi F., et al. The thymus in myasthenia gravis: site of "innate autoimmunity"?. Muscle Nerve 2011, 44:467-484.
4. Bernasconi P., Barberis M., Baggi F., Passerini L., Cannone M., Arnoldi E., et al. Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution. Am J Pathol 2005, 167:129-139.
5. Cufi P., Dragin N., Weiss J.M., Martinez-Martinez P., De Baets M.H., Roussin R., et al. Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis. Ann Neurol 2013, 73:281-293.
6. Cavalcante P., Cufi P., Mantegazza R., Berrih-Aknin S., Bernasconi P., Le Panse R. Etiology of myasthenia gravis: innate immunity signature in pathological thymus. Autoimmun Rev 2013, 12:863-874.
7. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000, 1:398-401.
8. Cavalcante P., Barberis M., Cannone M., Baggi F., Antozzi C., Maggi L., et al. Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis. Neurology 2010, 74:1118-1126.
9. Gradolatto A., Nazzal D., Foti M., Bismuth J., Truffault F., Le Panse R., et al. Defects of immunoregulatory mechanisms in myasthenia gravis: role of IL-17. Ann N Y Acad Sci 2012, 1274:40-47.
10. Sallusto F., Lanzavecchia A., Mackay C.R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998, 19:568-574.
11. Imai T., Nagira M., Takagi S., Kakizaki M., Nishimura M., Wang J., et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999, 11:81-88.
12. Vulcano M., Albanesi C., Stoppacciaro A., Bagnati R., D'Amico G., Struyf S., et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 invitro and invivo. Eur J Immunol 2001, 31:812-822.
13. Penna G., Vulcano M., Sozzani S., Adorini L. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol 2002, 63:1164-1171.
14. Imai T., Baba M., Nishimura M., Kakizaki M., Takagi S., Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. JBiol Chem 1997, 272:15036-15042.
15. Imai T., Chantry D., Raport C.J., Wood C.L., Nishimura M., Godiska R., et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. JBiol Chem 1998, 273:1764-1768.
16. Yuan Q., Bromley S.K., Means T.K., Jones K.J., Hayashi F., Bhan A.K., et al. CCR4-dependent regulatory T cell function in inflammatory bowel disease. JExp Med 2007, 204:1327-1334.
17. Stutte S., Quast T., Gerbitzki N., Savinko T., Novak N., Reifenberger J., et al. Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells. Proc Natl Acad Sci U S A 2010, 107:8736-8741.
18. Fu W., Chen W. Roles of chemokines in thymopoiesis: redundancy and regulation. Cell Mol Immunol 2004, 1:266-273.
19. Waite J.C., Skokos D. Th17 response and inflammatory autoimmune diseases. Int J Inflam 2012, 2012:819467.
20. Baggi F., Antozzi C., Toscani C., Cordiglieri C. Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?. Arch Immunol Ther Exp (Warsz) 2012, 60:19-30.
21. Baggi F., Annoni A., Ubiali F., Milani M., Longhi R., Scaioli W., et al. Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats. JImmunol 2004, 172:2697-2703.
22. Inoue H., Ohsawa I., Murakami T., Kimura A., Hakamata Y., Sato Y., et al. Development of new inbred transgenic strains of rats with LacZ or GFP. Biochem Biophys Res Commun 2005, 329:288-295.
23. Macagno A., Molteni M., Rinaldi A., Bertoni F., Lanzavecchia A., Rossetti C., et al. Acyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. JExp Med 2006, 203:1481-1492.
24. Marolda R., Ruocco C., Cordiglieri C., Toscani C., Antozzi C., Mantegazza R., et al. Differential targeting of immune-cells by Pixantrone in experimental myasthenia gravis. JNeuroimmunol 2013, 258:41-50.
25. Flugel A., Willem M., Berkowicz T., Wekerle H. Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat Med 1999, 5:843-847.
26. Kawakami N., Nagerl U.V., Odoardi F., Bonhoeffer T., Wekerle H., Flugel A. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. JExp Med 2005, 201:1805-1814.
27. Cordiglieri C., Odoardi F., Zhang B., Nebel M., Kawakami N., Klinkert W.E., et al. Nicotinic acid adenine dinucleotide phosphate-mediated calcium signalling in effector T cells regulates autoimmunity of the central nervous system. Brain 2010, 133:1930-1943.
28. Parker L.C., Whyte M.K., Vogel S.N., Dower S.K., Sabroe I. Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells. JImmunol 2004, 172:4977-4986.
29. Miller M.J., Hejazi A.S., Wei S.H., Cahalan M.D., Parker I. Tcell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc Natl Acad Sci U S A 2004, 101:998-1003.
30. Miller M.J., Safrina O., Parker I., Cahalan M.D. Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. JExp Med 2004, 200:847-856.
31. Tadokoro C.E., Shakhar G., Shen S., Ding Y., Lino A.C., Maraver A., et al. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells invivo. JExp Med 2006, 203:505-511.
32. Tomiyama T., Ueda Y., Katakai T., Kondo N., Okazaki K., Kinashi T. Antigen-specific suppression and immunological synapse formation by regulatory T cells require the mst1 kinase. PLoS One 2013, 8:e73874.
33. Flugel A., Berkowicz T., Ritter T., Labeur M., Jenne D.E., Li Z., et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001, 14:547-560.
34. Le Panse R., Berrih-Aknin S. Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation. Curr Opin Neurol 2013, 26:569-576.
35. Le Panse R., Bismuth J., Cizeron-Clairac G., Weiss J.M., Cufi P., Dartevelle P., et al. Thymic remodeling associated with hyperplasia in myasthenia gravis. Autoimmunity 2010, 43:401-412.
36. Weiss J.M., Cufi P., Bismuth J., Eymard B., Fadel E., Berrih-Aknin S., et al. SDF-1/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients. Immunobiology 2013, 218:373-381.
37. Lim H.W., Lee J., Hillsamer P., Kim C.H. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. JImmunol 2008, 180:122-129.
38. Poppensieker K., Otte D.M., Schurmann B., Limmer A., Dresing P., Drews E., et al. CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells. Proc Natl Acad Sci U S A 2012, 109:3897-3902.
39. Galimberti D., Fenoglio C., Comi C., Scalabrini D., De Riz M., Leone M., et al. MDC/CCL22 intrathecal levels in patients with multiple sclerosis. Mult Scler 2008, 14:547-549.
40. Flytlie H.A., Hvid M., Lindgreen E., Kofod-Olsen E., Petersen E.L., Jorgensen A., et al. Expression of MDC/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Cytokine 2010, 49:24-29.
41. Annunziato F., Romagnani P., Cosmi L., Lazzeri E., Romagnani S. Chemokines and lymphopoiesis in human thymus. Trends Immunol 2001, 22:277-281.
42. Watanabe N., Wang Y.H., Lee H.K., Ito T., Wang Y.H., Cao W., et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005, 436:1181-1185.
43. Wu M., Fang H., Hwang S.T. Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells. JImmunol 2001, 167:4791-4795.
44. Henry C.J., Ornelles D.A., Mitchell L.M., Brzoza-Lewis K.L., Hiltbold E.M. IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17. JImmunol 2008, 181:8576-8584.
45. Matsui N., Nakane S., Saito F., Ohigashi I., Nakagawa Y., Kurobe H., et al. Undiminished regulatory T cells in the thymus of patients with myasthenia gravis. Neurology 2010, 74:816-820.
46. Gertel-Lapter S., Mizrachi K., Berrih-Aknin S., Fuchs S., Souroujon M.C. Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model. Autoimmun Rev 2013, 12:894-903.
47. Hemdan N.Y., Birkenmeier G., Wichmann G., Abu El-Saad A.M., Krieger T., Conrad K., et al. Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev 2010, 9:785-792.
48. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010, 10:479-489.
49. Voo K.S., Wang Y.H., Santori F.R., Boggiano C., Wang Y.H., Arima K., et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A 2009, 106:4793-4798.
50. Wakkach A., Guyon T., Bruand C., Tzartos S., Cohen-Kaminsky S., Berrih-Aknin S. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis. JImmunol 1996, 157:3752-3760.
51. Schluep M., Willcox N., Vincent A., Dhoot G.K., Newsom-Davis J. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann Neurol 1987, 22:212-222.
52. Hill M.E., Shiono H., Newsom-Davis J., Willcox N. The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics. JNeuroimmunol 2008, 201-202:50-56.
53. Melms A., Schalke B.C., Kirchner T., Muller-Hermelink H.K., Albert E., Wekerle H. Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. JClin Invest 1988, 81:902-908.
54. Miyasaka M., Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 2004, 4:360-370.
55. Germain R.N., Robey E.A., Cahalan M.D. Adecade of imaging cellular motility and interaction dynamics in the immune system. Science 2012, 336:1676-1681.
56. Miller M.J., Wei S.H., Parker I., Cahalan M.D. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 2002, 296:1869-1873.
57. Stoll S., Delon J., Brotz T.M., Germain R.N. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 2002, 296:1873-1876.
58. Qi H., Egen J.G., Huang A.Y., Germain R.N. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 2006, 312:1672-1676.
59. Chtanova T., Han S.J., Schaeffer M., van Dooren G.G., Herzmark P., Striepen B., et al. Dynamics of T cell, antigen-presenting cell, and pathogen interactions during recall responses in the lymph node. Immunity 2009, 31:342-355.
60. Bartholomaus I., Kawakami N., Odoardi F., Schlager C., Miljkovic D., Ellwart J.W., et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009, 462:94-98.
61. Lodygin D., Odoardi F., Schlager C., Korner H., Kitz A., Nosov M., et al. Acombination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity. Nat Med 2013, 19:784-790.
62. Adjobimey T., Satoguina J., Oldenburg J., Hoerauf A., Layland L.E. Co-activation through TLR4 and TLR9 but not TLR2 skews Treg-mediated modulation of Igs and induces IL-17 secretion in Treg:B cell co-cultures. Innate Immun 2014, 20(1):12-23. [Epub 2013 Mar 25].
63. Eisenbarth S.C., Piggott D.A., Huleatt J.W., Visintin I., Herrick C.A., Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. JExp Med 2002, 196:1645-1651.
64. Cavanagh L.L., Weninger W. Dendritic cell behaviour invivo: lessons learned from intravital two-photon microscopy. Immunol Cell Biol 2008, 86:428-438.
65. Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
66. Gomez-Martin D., Diaz-Zamudio M., Romo-Tena J., Ibarra-Sanchez M.J., Alcocer-Varela J. Follicular helper T cells poise immune responses to the development of autoimmune pathology. Autoimmun Rev 2011, 10:325-330.
67. Luo C., Li Y., Liu W., Feng H., Wang H., Huang X., et al. Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis. JNeuroimmunol 2013, 256:55-61.
68. Xie X., Mu L., Yao X., Li N., Sun B., Li Y., et al. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles. Clin Immunol 2013, 148:162-176.